Beryl Drugs P/E Ratio
Current P/E Ratio
18.66
Moderate Valuation
Moderate - Fairly valued
Beryl Drugs (BERLDRG) P/E ratio is 18.66 (Moderate), EPS (TTM) ₹0.84, current price ₹23.00 on BSE — Moderate - Fairly valued. For live price, revenue and the complete fundamental profile, see Beryl Drugs share price chart.
Current Valuation Metrics
P/E Ratio
18.66
Current Price
₹23.00
EPS (TTM)
₹0.84
Exchange
BSE
Valuation Signal
Signal
Fairly Valued
Sector Context
Sector Average
55.66
Sector Median
31.02
Sector Rank
#11 of 195
Sector Percentile
5.6%
BERLDRG P/E Ratio — Valuation Signal & Historical Context
Beryl Drugs P/E 18.66 — signal: Fairly Valued. Read BERLDRG dividend history for the complete payout history and dividend yield track record.
- Trading at discount to sector average PE of 55.66
BERLDRG vs Healthcare Peers — P/E Ratio Comparison
Beryl Drugs P/E 18.66 vs Healthcare average 55.66, median 31.02 — range 2.86–712.0.
Sector Average
55.66
Sector Median
31.02
Lowest P/E
2.86
Highest P/E
712.0
Companies
195
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.29 | ₹53 | Low |
| Colinz Laboratories | COLINZ | 3.6 | ₹10 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.05 | ₹6,404 | Low |
| Sunrest Lifescience | SUNREST | 4.08 | ₹65 | Low |
| Shelter Pharma | SHELTER | 4.85 | ₹44 | Low |
| GKB Ophthalmics | GKB | 5.94 | ₹33 | Low |
| JFL Life Sciences | JFLLIFE | 6.44 | ₹86 | Low |
| Dipna Pharmachem | DPL | 6.52 | ₹18 | Low |
| Royal Sense | ROYAL | 7.11 | ₹51 | Low |